Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type
Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type
Open-label treatment with MPC-7869 for participants in a previous randomized study.
Inclusion Criteria:
Exclusion Criteria:
Fort Meyers, Florida, United States
Winnepeg, Manitoba, Canada